MeritValue

Glucose Health, Inc.

GLUCdata completeness 75%7 fiscal years on file
The thesis, from the filings

Glucose Health, Inc. earns about -1798% on equity, and has bought back 63% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below. Whether it’s worth owning at today’s price is the last question — and yours to answer, below.

i. The business — what you’d actually own
FigureFY 2012FY 2013FY 2014FY 2015FY 2016
Revenue—$2241$2,7392$4,2723$313,2293
Net income−$399,0784−$1.46M5−$669,4096−$266,0647−$410,4437
Operating cash flow−$83,6918−$131,9859−$135,35210−$115,77611−$39,26311
Capital expenditure—————
Free cash flow (derived)—————
Total debt$60,68012$78,71513$169,92313——
Cash & equivalents$1,07614$71115$4,87116$2,05516$20,54216
Diluted shares7.6M297,225675,1552.0M2.8M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom). A derived or summed figure cites every filing line it was built from.

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$1.77
your share of equity
Profit it earned you last year
−$1.47
Free cash flow it threw off
—
Debt you’d be carrying
—

10 shares is a claim on −$1.77 of net worth that earned you −$1.47 last year.

iii. Is this a good business?
Moat signal · return on equity
-1798% avg · 5y
FY12 -1798%FY13 —FY14 —FY15 —FY16 —

It earned an average -1798% on equity over 5 years. Compare that to what it costs to fund the business.

seeing a moat in the numbers →
Management signal · capital allocation
−63% shares · 5y

Share count is down 63% over 5 years — management has been buying back stock, quietly handing owners a bigger slice. Total debt has risen 180% over the same window.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.6.0
DCF · Growth Exit 10Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Beyond this page

This page is free, and so is every other company on MeritValue.

In your AI assistant

Connect the MeritValue MCP server to Claude or another MCP client, ask about Glucose Health, Inc., and get these exact figures with their filing receipts — not an improvised DCF.

Get a free key →
Screen by model

Pull the companies with a published value under any model (up to 500 a request, filtered by data completeness) into your own sheet or agent. Screening is what Analyst adds, at $9/month.

See pricing →
On iPhone

Follow GLUC and keep your own price beside the value. The same engine, with the same receipts.

MeritValue on the App Store →
Sources — the receipts
  1. 10-K filed 2015-03-30 · period ending 2013-12-31 · accession 0001477932-15-001981 (SalesRevenueGoodsNet)
  2. 10-K filed 2016-04-14 · period ending 2014-12-31 · accession 0001477932-16-009786 (SalesRevenueGoodsNet)
  3. 10-K filed 2017-03-29 · periods ending 2015-12-31, 2016-12-31 · accession 0001477932-17-001354 (SalesRevenueGoodsNet)
  4. 10-K filed 2014-06-25 · period ending 2012-12-31 · accession 0001477932-14-003318 (NetIncomeLoss)
  5. 10-K filed 2015-03-30 · period ending 2013-12-31 · accession 0001477932-15-001981 (NetIncomeLoss)
  6. 10-K filed 2016-04-14 · period ending 2014-12-31 · accession 0001477932-16-009786 (NetIncomeLoss)
  7. 10-K filed 2017-03-29 · periods ending 2015-12-31, 2016-12-31 · accession 0001477932-17-001354 (NetIncomeLoss)
  8. 10-K filed 2014-06-25 · period ending 2012-12-31 · accession 0001477932-14-003318 (NetCashProvidedByUsedInOperatingActivities)
  9. 10-K filed 2015-03-30 · period ending 2013-12-31 · accession 0001477932-15-001981 (NetCashProvidedByUsedInOperatingActivities)
  10. 10-K filed 2016-04-14 · period ending 2014-12-31 · accession 0001477932-16-009786 (NetCashProvidedByUsedInOperatingActivities)
  11. 10-K filed 2017-03-29 · periods ending 2015-12-31, 2016-12-31 · accession 0001477932-17-001354 (NetCashProvidedByUsedInOperatingActivities)
  12. 10-K/A filed 2014-05-05 · period ending 2012-12-31 · accession 0001477932-14-002329 (ShortTermBankLoansAndNotesPayable)
  13. 10-K filed 2015-03-30 · periods ending 2013-12-31, 2014-12-31 · accession 0001477932-15-001981 (DebtCurrent)
  14. 10-K filed 2015-03-30 · period ending 2012-12-31 · accession 0001477932-15-001981 (CashAndCashEquivalentsAtCarryingValue)
  15. 10-K filed 2016-04-14 · period ending 2013-12-31 · accession 0001477932-16-009786 (CashAndCashEquivalentsAtCarryingValue)
  16. 10-K filed 2017-03-29 · periods ending 2014-12-31, 2015-12-31, 2016-12-31 · accession 0001477932-17-001354 (CashAndCashEquivalentsAtCarryingValue)